Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1546-0096
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trial ; volume:17 ; number:1 ; day:22 ; month:8 ; year:2019 ; pages:1-10 ; date:12.2019
Pediatric rheumatology ; 17, Heft 1 (22.8.2019), 1-10, 12.2019
- Urheber
-
Mallalieu, Navita L.
Wimalasundera, Sunethra
Hsu, Joy C.
Douglass, Wendy
Wells, Chris
Penades, Inmaculada Calvo
Cuttica, Ruben
Huppertz, Hans-Iko
Joos, Rik
Kimura, Yukiko
Milojevic, Diana
Rosenkranz, Margalit
Schikler, Kenneth
Constantin, Tamas
Wouters, Carine
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12969-019-0364-z
- URN
-
urn:nbn:de:101:1-2020010523381080975545
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mallalieu, Navita L.
- Wimalasundera, Sunethra
- Hsu, Joy C.
- Douglass, Wendy
- Wells, Chris
- Penades, Inmaculada Calvo
- Cuttica, Ruben
- Huppertz, Hans-Iko
- Joos, Rik
- Kimura, Yukiko
- Milojevic, Diana
- Rosenkranz, Margalit
- Schikler, Kenneth
- Constantin, Tamas
- Wouters, Carine
- SpringerLink (Online service)
Ähnliche Objekte (12)
Dosing of Intravenous Tocilizumab in a Real-World Setting of Rheumatoid Arthritis: Analyses from the Corrona Registry
Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis
Optimizing the Dosing of Intravenous Theophylline in Acute Severe Asthma in Children
Younger and Younger
Efficacious switching from subcutaneous to intravenous tocilizumab in patients with non-infectious non-anterior uveitis
Use of intravenous tocilizumab in pregnancy for severe coronavirus disease 2019 pneumonia: two case reports
Intravenous furosemide in decompensated heart failure: do not protocolize dosing but the desired effect!
Intravenous Vancomycin Dosing in the Elderly: A Focus on Clinical Issues and Practical Application
Pediatric Dosing of Intravenous Sotalol Based on Body Surface Area in Patients with Arrhythmia
Intravenous tocilizumab for the treatment of giant cell arteritis: a phase Ib dose-ranging pharmacokinetic bridging study
Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study
Severe Adult Still’s Disease Complicated by Purtscher-Like Retinopathy Treated with Intravenous Pulse Methylprednisolone and Tocilizumab
Dosing of Intravenous Tocilizumab in a Real-World Setting of Rheumatoid Arthritis: Analyses from the Corrona Registry
Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis
Optimizing the Dosing of Intravenous Theophylline in Acute Severe Asthma in Children
Younger and Younger
Efficacious switching from subcutaneous to intravenous tocilizumab in patients with non-infectious non-anterior uveitis
Use of intravenous tocilizumab in pregnancy for severe coronavirus disease 2019 pneumonia: two case reports
Intravenous furosemide in decompensated heart failure: do not protocolize dosing but the desired effect!
Intravenous Vancomycin Dosing in the Elderly: A Focus on Clinical Issues and Practical Application
Pediatric Dosing of Intravenous Sotalol Based on Body Surface Area in Patients with Arrhythmia
Intravenous tocilizumab for the treatment of giant cell arteritis: a phase Ib dose-ranging pharmacokinetic bridging study
Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study
Severe Adult Still’s Disease Complicated by Purtscher-Like Retinopathy Treated with Intravenous Pulse Methylprednisolone and Tocilizumab
Dosing of Intravenous Tocilizumab in a Real-World Setting of Rheumatoid Arthritis: Analyses from the Corrona Registry
Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis
Optimizing the Dosing of Intravenous Theophylline in Acute Severe Asthma in Children
Younger and Younger
Efficacious switching from subcutaneous to intravenous tocilizumab in patients with non-infectious non-anterior uveitis
Use of intravenous tocilizumab in pregnancy for severe coronavirus disease 2019 pneumonia: two case reports
Intravenous furosemide in decompensated heart failure: do not protocolize dosing but the desired effect!
Intravenous Vancomycin Dosing in the Elderly: A Focus on Clinical Issues and Practical Application
Pediatric Dosing of Intravenous Sotalol Based on Body Surface Area in Patients with Arrhythmia
Intravenous tocilizumab for the treatment of giant cell arteritis: a phase Ib dose-ranging pharmacokinetic bridging study
Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study